CAS-ViewAlert

View Alert




Originator:		MHRA Drug Alerts
From:		Himal Makwana
Issue date:		19-Mar-2020 13:59:20
This alert has been issued to:
		NHS Regional Offices NHS Foundation Trusts (England) - Medical Director NHS Trusts (England) - Medical Director Territorial CMOs in Northern Ireland, Scotland & Wales
		MHRA (Medicines) Drug Alerts (Various Recipients) Other contacts Independent Healthcare Providers (registered with CAS) Clinical Commissioning Groups NHS Foundation Trusts (England) - Chief Executive MHRA (Medicines) Drug Alerts - Non-NHS Recipients Regional Directors of Public Health Director of Public Health NHS Trusts (England) - Chief Executive NHS 111 and Out of hours providers Dispensing GP Practices Primary Care Networks
Action category:		Class 4: For information
Title:		CLASS 4 FMD DRUG ALERT, FOR INFORMATION, HMS WHOLESALE LTD WDA(H) 50340, MULTIPLE PRODUCTS - SEE ALERT FOR MORE INFORMATION
Broadcast content:		The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via WDA(H) 50340 HMS Wholesale Limited. This License has now been terminated. The products do appear to be genuine with legitimate batch numbers. These products are thought to have been stolen from the legitimate supply chain in early 2019 and reintroduced into the supply chain between May and August 2019. This means that the correct transport and storage conditions cannot be guaranteed and while unlikely, could impact their effectiveness. Only the batch numbers mentioned in appendix 1 of the PDF are within the scope of this alert. If you have received any of these batches listed in appendix 1, from WDA(H) 50340 HMS Wholesale Limited, please contact DMRC/MHRA. Full details of the drug alert are included in the attached PDF file. Please forward to listed recipients. This information is also published on the MHRA website https://www.gov.uk/drug-device-alerts. Falsified Medicines Directive (FMD) 2011/62/EU introduced new requirements to enhance the security of the European supply chain. Where the MHRA has identified risks to the security of the supply chain, FMD Alerts will be issued. For further information about FMD and safety features, please see this link on GOV.UK.
Additional information:		NHS England Regional Offices: Please cascade this alert to Community Pharmacy and any Dispensing GP Practices not yet registered with CAS. GP Practices: This alert applies to Dispensing GP Practices only.
Alert reference:		EL (20)A/17
Attachments:		EL (20)A 17 Final.pdf
Cascade to:		#COMMUNITYPHARMACISTS# #DISPENSING GP# #HospitalPharmacy#